miR-23a-3p is a Key Regulator of IL-17C-Induced Tumor Angiogenesis in Colorectal Cancer
Open Access
- 1 June 2020
- Vol. 9 (6), 1363
- https://doi.org/10.3390/cells9061363
Abstract
MicroRNAs (miRNAs) have emerged as key players in tumor angiogenesis. Interleukin-17C (IL-17C) was identified to promote colorectal cancer (CRC) progression. Therefore, we aimed to investigate the effect of IL-17C on tumor angiogenesis, the involvement of miR-23a-3p in IL-17C signaling, and the direct target gene of miR-23a-3p in CRC. In vitro and ex vivo angiogenesis, a mouse xenograft experiment, and immunostaining were performed to test the effect of IL-17C on tumor angiogenesis. ELISA, quantitative real time PCR, and gene silencing were used to uncover the underlying mechanism. IL-17C induced angiogenesis of intestinal endothelial cells, subsequently enhancing cell invasion and migration of DLD-1 cells. IL-17C-stimulated DLD-1 cells produced vascular endothelial growth factor (VEGF) to enhance angiogenesis. Moreover, IL-17C markedly accelerated xenograft tumor growth, which was manifested by substantially reduced tumor growth when treated with the VEGF receptor 2 inhibitor Ki8751. Accordingly, Ki8751 suppressed the expression of IL-17C-stimulated PECAM and VE-cadherin in xenografts. Furthermore, IL-17C activated STAT3 to increase the expression of miR-23a-3p that suppressed semaphorin 6D (SEMA6D) expression, thereby permitting VEGF production. Taken together, our study demonstrates that IL-17C promotes tumor angiogenesis through VEGF production via a STAT3/miR-23a-3p/SEMA6D axis, suggesting its potential as a novel target for anti-CRC therapy.Funding Information
- National Research Foundation of Korea (2019R1A2C1010536)
This publication has 45 references indexed in Scilit:
- Epigenetic and genetic features of 24 colon cancer cell linesOncogenesis, 2013
- The role of semaphorins and their receptors in vascular development and cancerExperimental Cell Research, 2013
- Roles for MicroRNAs in Conferring Robustness to Biological ProcessesCell, 2012
- IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinomaMolecular Cancer, 2011
- IL-17C regulates the innate immune function of epithelial cells in an autocrine mannerNature Immunology, 2011
- IL-17RE is the functional receptor for IL-17C and mediates mucosal immunity to infection with intestinal pathogensNature Immunology, 2011
- Semaphorin-PlexinD1 Signaling Limits Angiogenic Potential via the VEGF Decoy Receptor sFlt1Developmental Cell, 2011
- Regulation of angiogenesis and choroidal neovascularization by members of microRNA-23∼27∼24 clustersProceedings of the National Academy of Sciences of the United States of America, 2011
- IL-17 can promote tumor growth through an IL-6–Stat3 signaling pathwayThe Journal of Experimental Medicine, 2009
- The prevalence of Th17 cells in patients with gastric cancerBiochemical and Biophysical Research Communications, 2008